Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

New Listing & Already Profitable? How This Gaming Company is Capturing the Market

(Image via PopReach) The video game market has gone from an entertainment afterthought in the 2000’s to the largest media market in the world. But what’s the best way for investors to play in the space? Many instinctively look to th...
Stockhouse Editorial | July 8, 2020 |

Gaming stocks that are worth tracking

Gaming has evolved from a pastime activity to become a career for some people and an educational tool for others. Gaming has produced some of the biggest global companies, such as Sony, Meta, Microsoft, and Tencent Holdings. How did companies like Microsoft and Meta get a...
Research | July 29, 2024 |

Ready for Prime Time: Patriot One Technologies Partners with Tech Giants as Commercialization Begins

This small-cap firm's threat detection products have evolved from a single technology to a multi-sensor threat detection platform. With mass shootings becoming all too commonplace, Patriot One Technologies Inc. (PAT:TSX; PTOTF:OTCQX) has been working to develop a th...
Streetwise Reports | November 14, 2019 |

Ximen Mining ESG Reporting: Kenville Gold Mine Hydrogeology

(Click to watch video) As part of a continued commitment to ESG reporting, Ximen Mining is pleased to share summarized results from a hydrogeology assessment completed for the Company’s 100% owned Kenville Gold Mine project in Nelson, southea...
Featured Submission | July 29, 2021 |

SunPower (SPWRA): Retreating into familiar territory

Last week, SunPower Corporation ( NASDAQ: SPWRA , Stock Forum ) updated its 2011 guidance, predicting that ex-items earnings per share would range between $1.75 and $2.05. Revenue for the upcoming fiscal year is predicted to arrive between $2.65 billion and $2.85 billion....
Andrea Kramer | October 28, 2012 |

Blackrock Gold, Continental, Siemens: Spin-Off as driver of share price

In the case of growing and large companies, the decision may be made in the course of development that part of the operational business be formed into a separate entity. A so-called spin-off or spin-out can have various advantages. On the one hand, capital-intensive businesses...
Mario Hose | September 16, 2020 |

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Co

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Conducted by Aethlon's Exosome Sciences Subsidiary Source: Gail Dutton of The Life Sciences Report (12/22/15) https://www.thelifesciencesreport.com/pub/na/aethlon-medical...
Gail Dutton | December 23, 2015 |

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...
Streetwise Reports | September 12, 2019 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

Ra Pharmaceuticals Shares Up 100% Following $2.1 Billion Takeover Bid

Shares of Ra Pharmaceuticals doubled today after the firm announced that it will be acquired by Belgian firm UCB for $48 per share in an all cash deal. Prior to the market open this morning Ra Pharmaceuticals Inc. (RARX:NASDAQ) and Brussels-based UCB (UCB:Euronext)...
Streetwise Reports | October 11, 2019 |
1 2 3 4